COVID-19 vaccine effectiveness and community prevalence of Alpha, Delta and Omicron variants in patients with cirrhosis

Gut. 2023 Sep;72(9):1800-1802. doi: 10.1136/gutjnl-2022-327799. Epub 2022 Sep 5.
No abstract available

Keywords: CIRRHOSIS; COVID-19.

Publication types

  • Letter
  • Research Support, N.I.H., Extramural
  • Comment

MeSH terms

  • COVID-19 Vaccines*
  • COVID-19* / epidemiology
  • COVID-19* / prevention & control
  • Humans
  • Liver Cirrhosis / complications
  • Liver Cirrhosis / epidemiology
  • Prevalence
  • SARS-CoV-2
  • Vaccine Efficacy

Substances

  • COVID-19 Vaccines

Supplementary concepts

  • SARS-CoV-2 variants